Inflammation: A possible pathogenic link to cardiac syndrome X

Medical Hypotheses

Volumn 66, Issue 1, 2006, Pages 87-91

  Li, Jian Jun ^a   Li, Yi Shi ^a   Zhang, Yuen ^a   Gao, Zhan ^a   Li, Zheng ^a   Qian, Hai Yan ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; DOBUTAMINE; ERGOMETRINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC INFLAMMATION; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; EXERCISE TEST; EXERCISE TOLERANCE; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; MICROANGIOPATHY; NOCICEPTION; PAIN; PAIN THRESHOLD; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SYNDROME X; TREADMILL EXERCISE;

CORONARY VESSELS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MICROCIRCULATION; MICROVASCULAR ANGINA;

EID: 27744461415     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.08.005     Document Type: Article

References (39)

1. J.-J. Li Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis Med Hypotheses 63 2004 100 102
2. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
3. J-J Li, and H-R Wang Enhanced response of blood monocytes to C-reactive protein in patients with unstable angina Clin Chim Acta 352 22 2004 127 133
4. J.-J. Li Silent myocardial ischemia may be related to inflammatory response Med Hypotheses 62 2004 252 256
5. J.-J. Li, H. Jiang, and C.-X. Huang Elevated C-reactive protein of plasma in patients with unstable angina: its relations with coronary stenosis and lipid profile Angiology 53 3 2002 265 272
6. J.-J. Li, G.-S. Li, C.-H. Fang, and M.-Z. Chen Activation of nuclear factor-κB and correlation with elevated plasma C-reactive protein in patients with unstable angina Heart Lung Circ 13 2004 173 178
7. J.-J. Li, C.-H. Fang, and H. Jiang Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal artery stenosis Clin Chim Acta 350 2004 115 121
8. C.-H. Fang, and J.-J. Li Statin, like aspirin, should be given as early as possible in patients with acute coronary syndrome Med Hypotheses 64 2004 192 196
9. J.-J. Li Early, intensive and long-term statin therapy in acute coronary syndrome: focus on an anti-inflammatory mechanism Vasc Dis Prevent 2 3 2005 340 347
10. J.-J. Li Effects of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina Clin Chim Acta 352 2005 217 224
11. J.-J. Li, and X.-J. Chen Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein as well as lipopolysaccharide Coron Artery Dis 14 2003 329 334
12. J.-J. Li Rapid effects on lipid profile and C-reactive protein by simvastatin in patients with hypercholesterolemia Clin Cardiol 26 2003 472 476
13. J.-J. Li, and C.-H. Fang Effect of a single high-dose of simvastatin on C-reactive protein in patients with unstable angina Heart Drug 5 2005 140 145
14. H.-R. Wang, J.-J. Li, and C.-X. Huang Fluvastatin inhibits the expression of tumor necrosis factor-α and activation of nuclear factor-κB in endothelial cells stimulated by C-reactive protein Clin Chim Acta 353 2005 53 60
15. J.-J. Li, Y.-L. Guo, and Y.-J. Yang Enhancing anti-inflammatory IL-10 may be beneficial for acute coronary syndrome Med Hypotheses 65 2005 103 106
16. Li J-J, Li Y-S, Chu J-M, et al. Changes of plasma pro-inflammatory response after withdrawal of a statin therapy in patients with hyperlipidemia. Clin Chim Acta [submitted for publication].
17. J-J Li, and C-H Fang Effects of 4 weeks of atorvastatin administration on the anti-inflammatory cytokine interleukin-10 in patients with unstable angina Clin Chem 51 2005 1735 1738
18. R.O. Cannon, and S.E. Epstein "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries Am J Cardiol 61 1988 1338 1343
19. F. Crea, and G.A. Lanza Angina pectoris and normal coronary arteries: cardiac syndrome X Heart 90 2004 457 463
20. A. Dominguez-Rodriguez, M. Garcia-Gonzalez, and P. Abreu-Gonzalez Cardiac syndrome X: diagnosis, pathogenesis and management Am J Cardiovasc Drugs 4 2004 423 424
21. A. Maseri, F. Crea, and J.C. Kaski Mechanisms of angina pectoris in syndrome X J Am Coll Cardiol 17 1991 499 506
22. R.O. Cannon, P.G. Camici, and S.E. Epstein Pathophysiological dilemma of syndrome X Circulation 85 1992 883 892
23. G.A. Lanza, A. Sestito, and G. Cammarota Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X Am J Cardiol 94 2004 40 44
24. J. Cosin-Sales, C. Pizzi, S. Brown, and J.C. Kaski C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary artery J Am Coll Cardiol 41 2003 1468 1474
25. C.P. Lin, W.T. Lin, H.B. Leu, T.C. Wu, and J.W. Chen Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X Int J Cardiol 89 2003 53 62
26. F. Tomai C-reactive protein and microvascular function Heart 90 2004 727 728
27. R. Arroyo-Espliguero, N. Mollichelli, and P. Avanzas Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome Eur Heart J 24 2003 2006 2011
28. E.A. Asbury, F. Creed, and P. Collins Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X Eur Heart J 25 2003 1695 1701
29. M. Kayikcioglu, S. Payzin, and O. Yavuzgi Benefits of statin treatment in cardiac syndrome-X Eur Heart J 24 2003 1999 2005
30. R.S. Rosenson Statin therapy: new therapy for cardiac microvascular dysfunction Eur Heart J 24 2003 1993 1994
31. C. Pizzi, O. Manfrini, F. Fontana, and R. Bugiardini Angiotensin- converting enzyme inhibitor and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X Circulation 109 2004 53 58
32. A. Chauhan, P.A. Mullins, and M. Taylor Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms Eur Heart J 18 1997 60 68
33. A. Buffon, S. Rigattieri, and S.A. Santini Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X Am J Physiol Heart Circ Physiol 279 2000 H2627 H2633
34. G.A. Lanza, T.F. Luscher, and V. Pasceri Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X Am J Cardiol 84 1999 1187 1191
35. S.D. Rosen, E. Paulesu, and R.J.S. Wise Central neural contributing to the perception of chest pain in cardiac syndrome X Heart 87 2002 513 519
36. V. Pasceri, G.A. Lanza, and A. Buffon Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X J Am Coll Cardiol 31 1998 62 66
37. G.A. Lanza, A.G. Giordano, and C. Pristipino Abnormal cardiac adrenergic never function in patient with syndrome X detected by [123] metaiodobenzylguanidine myocardial scitigraphy Circulation 96 1997 821 826
38. D. Tousoulis, G.J. Davies, and G. Asimakopoulos Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X) Clin Cardiol 24 2001 301 304
39. H. Teragawa, Y. Fukuda, and K. Matsuda Relation between C-reactive protein concentration and coronary microvascular endothelial function Heart 90 2004 750 754